94 filings
Page 3 of 5
6-K
dkmrv2sfxq0ligcwtoi
7 Feb 23
Current report (foreign)
8:37am
6-K
yl1hur3cdfi8d
2 Feb 23
Current report (foreign)
4:30pm
6-K
t1yu41kkc
2 Feb 23
Virax Biolabs’ CEO James Foster Issues Letter to Shareholders
7:35am
6-K
69zxy
4 Jan 23
Current report (foreign)
7:39am
6-K
3f5akpw6pwiib9
6 Dec 22
COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States
7:40am
424B3
0hefsfg42rb85
2 Dec 22
Prospectus supplement
4:17pm
EFFECT
664 k43r2apw
2 Dec 22
Notice of effectiveness
12:15am
CORRESP
mrrb759
29 Nov 22
Correspondence with SEC
12:00am
UPLOAD
okk6o0gu
25 Nov 22
Letter from SEC
12:00am
F-1
36xc z08t5eedq2v5
18 Nov 22
Registration statement (foreign)
5:39pm
6-K
3osryd iu881nux8
18 Nov 22
Current report (foreign)
5:20pm
6-K
bi6a0ey
15 Nov 22
Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales
7:36am
6-K
6t6p6
8 Nov 22
Virax Biolabs Group Limited Announces $3.8 Million Private Placement
4:56pm
6-K
altv s5oc
3 Nov 22
Current report (foreign)
8:03am
6-K
0uya1b39u
26 Oct 22
Virax Biolabs Group Limited Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study
7:56am
6-K
zuhym7e1 ohd43w
22 Sep 22
Current report (foreign)
8:13am
6-K
jxx8 r03a
20 Sep 22
Current report (foreign)
8:02am
6-K
zykasuee
12 Sep 22
Virax BioLabs Presents at H.C. Wainwright’s 24th Annual Global Investment Conference
8:00am
6-K
45bg itrat5d
7 Sep 22
Virax BioLabs to Present at H.C. Wainwright’s 24th Annual Global Investment Conference in New York, NY
9:23am
20-F
8e08vnalrxik
12 Aug 22
Annual report (foreign)
4:20pm